Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Targeting NETs may help reduce fibrosis in Crohn's disease.

TNF-alpha inhibitors can cause various immune-related skin issues.

TAF can be identified by excessive skin thickening and clogged hair follicles, helping distinguish it from similar skin conditions.

Prompt treatment of inflammatory tinea capitis (kerion) is crucial to prevent scarring and hair loss.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Adalimumab improved folliculitis decalvans in most patients.

A rare scalp condition causing hair loss and cysts in young men can be treated effectively with a specific steroid injection.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

Inflammasome proteins may help diagnose and treat Parkinson's disease.

Hidradenitis suppurativa may be a type of autoinflammatory skin disease linked to gene mutations and immune system issues.

Reactive lipids from aging cells change the extracellular matrix, affecting cell function and inflammation.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Skin-associated adipocytes help protect the skin from infections by supporting its immune barrier.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Higher inflammation markers are linked to more severe alopecia areata.

Isotretinoin is effective for treating dissecting cellulitis, but recurrence is common.

Amyand's hernia treatment is complex and depends on literature and surgeon's experience.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.